# FDA 483 - Jawad A. Qureshi MD - October 21, 2020

Source: https://www.keypedia.com/records/483/jawad-a-qureshi-md/ff67daf8-7d9a-4948-a3d1-252feaa97638

> FDA 483 for Jawad A. Qureshi MD on October 21, 2020. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jawad A. Qureshi MD
- Inspection Date: 2020-10-21
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Jawad A. Qureshi MD in Grapevine, TX, revealed a significant deviation from the investigational plan during a clinical trial. The firm incorrectly administered investigational product to a study subject, necessitating an unscheduled follow-up visit. This indicates a failure to conduct the investigation in accordance with the signed statement of investigator and the approved plan.

## Related Officers

- [Assistant Country Director, Regulatory Specialist BIMO](https://www.keypedia.com/people/alanna-l-mussawwir-bias/1283ff1a-34dd-4d90-9389-7bff2570527d)

Company: https://www.keypedia.com/companies/jawad-a-qureshi-md/002cb738-0941-47a8-96b1-a07bd5f311ec

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab